Emerging trends in phase II trial design

Saved in:

Bibliographic Details
Other Authors:	Tang, Patricia (Speaker)
Format:	Electronic Video
Language:	English
Published:	London : Henry Stewart Talks, 2009.
Series:	Henry Stewart talks. Biomedical & life sciences collection. Cancer therapy : latest thinking in efficacy and toxicity.
Subjects:	Neoplasms > complications. Neoplasms > therapy.
Online Access:	https://hstalks.com/bs/1322/ Series
Tags:	Add Tag No Tags, Be the first to tag this record!

MARC


LEADER	00000ngm a2200000 a 4500
001	HST2288_1_2
003	UkLoHST
006	m c
007	cr\|cna\|\|\|a\|\|\|\|
007	vz\|czazum
008	080121s2009 enk\|\|\|\|\|\|\|\|\|\|\|s\|\|\|v\|eng d
028	5	0	\|a 2288 \|b Henry Stewart Talks
035			\|a (UkLoHST)1322
035			\|a (UkLU-K)001155639
040			\|a UkLU-K \|b eng \|c UkLU-K
100	1		\|a Tang, Patricia, \|u (Tom Baker Cancer Centre, Calgary, Canada) \|4 spk \|9 109557
245	1	0	\|a Emerging trends in phase II trial design \|h [electronic resource] / \|c Patricia Tang.
260			\|a London : \|b Henry Stewart Talks, \|c 2009.
300			\|a 1 online resource (1 streaming video file (42 min.) : \|b color, sound).
490	1		\|a Cancer therapy : latest thinking in efficacy and toxicity, \|x 2056-452X
500			\|a Animated audio-visual presentation with synchonized narration.
500			\|a Title from title frames.
505	0		\|a Contents: Purpose of phase II trials -- Advantages and disadvantages of common phase II trial designs -- Incorporation of correlative studies.
506			\|a Access restricted to subscribers.
538			\|a Mode of access: World Wide Web.
650		2	\|a Neoplasms \|x complications. \|9 109558
650		2	\|a Neoplasms \|x therapy. \|9 109559
830		0	\|a Henry Stewart talks. \|p Biomedical & life sciences collection. \|p Cancer therapy : latest thinking in efficacy and toxicity. \|9 109560
856	4	0	\|u https://hstalks.com/bs/1322/
856	4	2	\|u https://hstalks.com/bs/p/385/ \|3 Series
999			\|c 215772 \|d 215771